Pura Vida Investments’s Guardant Health GH Stock Holding History

Pura Vida Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-115,000	Closed	-$2.64M	–	28
2024 Q3	$2.64M	Buy	+115,000	New	+$3.25M	1.72%	24
2022 Q4	–	Sell	-400,000	Closed	-$21.5M	–	211
2022 Q3	$21.5M	Buy	400,000 +330,000	+471%	+$16.9M	1.25%	23
2022 Q2	$2.82M	Sell	70,000 -60,000	-46%	-$2.97M	0.16%	119
2022 Q1	$8.61M	Buy	+130,000	New	+$8.9M	0.28%	90
2021 Q4	–	Sell	-174,000	Closed	-$21.8M	–	266
2021 Q3	$21.8M	Buy	+174,000	New	+$20.7M	0.66%	35
2019 Q3	–	Sell	-142,200	Closed	-$12.3M	–	105
2019 Q2	$12.3M	Buy	142,200 +28,400	+25%	+$2.17M	1.86%	14
2019 Q1	$8.73M	Buy	+113,800	New	+$6.31M	1.24%	21

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pura Vida Investments's GH Position: Q2 2024 in Review

Pura Vida Investments sold out of Guardant Health (GH) in Q2 2024, closing a stake of 100,000 shares — an estimated $2.33M sold.

Pura Vida Investments first reported a position in GH in Q4 2018 and held it in 20 quarters. The position peaked at $21.6M in Q3 2022. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

Pura Vida Investments reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
Pura Vida Investments sold 100,000 Guardant Health shares in Q2 2024, an estimated $2.33M.
Pura Vida Investments first reported a position in Guardant Health in Q4 2018 and held it in 20 quarters.
Pura Vida Investments's Guardant Health position peaked at $21.6M in Q3 2022.
282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.